SHShan He

Shan He

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Shan He has a total of 47 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Polymerase Chain Reaction. Perturbation Theory and Machine Learning Artificial Intelligence‐Experimental Microbiome Analysis: Applications to Ancient DNA and Tree Soil Metagenomics Cases of Study

    by Jose L. Rodriguez, Estefania Ascencio, Jose M. Ageitos, Lucia Feijoo, Shan He, Amirreza Daghighi, Gerardo M. Casanola‐Martin, Cristian R. Munteanu, Santiago Rodriguez Yañez, Alejandro Pazos, et al.

    The exponential growth of genomic data has created a pressing need for methods capable of interpreting complex biological information, especially in fields like paleogenomics and environmental metagenomics. Ancient DNA (aDNA) analysis faces challenges such as degradation and contamination, while soil metagenomic DNA (soDNA) analysis is hindered by microbial diversity and incomplete reference databases. To address these limitations, this study proposes the polymerase chain reaction (PCR).Perturbation Theory and Machine Learning (PTML) methodology, which integrates machine learning with Perturbation Theory to analyze genetic sequences without the need for alignment. Two models are developed: the first classifies bacterial aDNA sequences extracted from Miocene amber; the second predicts tree health using microbial gene abundance in forest soils. Both rely on entropy‐based descriptors (θ k ) and structural differences (Δθ k ) between query and reference sequences, which serve as perturbation operators for supervised learning algorithms. This approach allows the detection of meaningful patterns even without complete genomic references. The aDNA model achieves 99.65% sensitivity and 99.81% specificity, while the soDNA model reaches 98.85% sensitivity and 92.56% specificity. These results confirm the robustness and applicability of PCR.PTML in diverse genomic contexts, presenting it as a valuable tool for ancient DNA classification and environmental metagenomics analysis.

  • IFPTML Multi-Output Model for Anti-Retroviral Compounds Including the Drug Structure and Target Protein Sequence Information

    by Emilia Vásquez-Domínguez, Shan He, Carlos Santolaria, Sonia Arrasate, Humbert González-Díaz

    Retroviruses such as HIV cause significant diseases in humans and other organisms, making the discovery of antiretroviral (ARV) drugs a critical priority. While databases like ChEMBL contain valuable information, their complexity poses challenges. The data set includes approximately >140,000 assays across eight viruses, encompassing >350 biological activity parameters, >50 target proteins, >80 cell lines, >60 assay organisms, and >770 viral strains. Artificial Intelligence/Machine Learning (AI/ML) models offer a promising approach to accelerate ARV discovery. Recently, we developed AI/ML models for ChEMBL ARV data using the Information Fusion Perturbation Theory and Machine Learning (IFPTML) strategy. However, neither existing AI/ML models nor our prior IFPTML implementation simultaneously incorporates viral protein sequences, strains, cell lines, assay organisms, or virus/human mutations. This limitation renders them ineffective for predicting activity against amino acid sequence variations (e.g., mutations, variants, or emerging strains)─a critical shortcoming given the well-documented prevalence of drug-resistance mutations in marketed ARVs. In this work, we present an enhanced IFPTML model integrating protein sequence descriptors. We computed and incorporated sequence descriptors for all drug target proteins in ChEMBL, derived from proteomes of retroviruses (HIV, FeLV, MMV, SIV, etc.). The model demonstrated robust performance, with sensitivity (Sn), specificity (Sp), and accuracy (Ac) values ranging between 72.0 and 88.0% in both training and validation phases. We analyze its predictions for protein mutations documented in ChEMBL and other literature sources. To our knowledge, this represents the first unified multicondition, multioutput model for ARV discovery that systematically accounts for protein sequence information.

  • Drug Release Nanoparticle System Design: Data Set Compilation and Machine Learning Modeling

    by Shan He, Ander Barón, Cristian R. Munteanu, Begoña de Bilbao, Gerardo M. Casañola-Martin, Mariana Chelu, Adina Magdalena Musuc, Harbil Bediaga, Estefania Ascencio, Idoia Castellanos-Rubio, et al.

    Magnetic nanoparticles (NPs) are gaining significant interest in the field of biomedical functional nanomaterials because of their distinctive chemical and physical characteristics, particularly in drug delivery and magnetic hyperthermia applications. In this paper, we experimentally synthesized and characterized new Fe3O4-based NPs, functionalizing its surface with a 5-TAMRA cadaverine modified copolymer consisting of PMAO and PEG. Despite these advancements, many combinations of NP cores and coatings remain unexplored. To address this, we created a new data set of NP systems from public sources. Herein, 11 different AI/ML algorithms were used to develop the predictive AI/ML models. The linear discriminant analysis (LDA) and random forest (RF) models showed high values of sensitivity and specificity (>0.9) in training/validation series and 3-fold cross validation, respectively. The AI/ML models are able to predict 14 output properties (CC50 (μM), EC50 (μM), inhibition (%), etc.) for all combinations of 54 different NP cores classes vs. 25 different coats and vs. 41 different cell lines, allowing the short listing of the best results for experimental assays. The results of this work may help to reduce the cost of traditional trial and error procedures.


  • Open Access

    Machine learning guided prediction of warfarin blood levels for personalized medicine based on clinical longitudinal data from cardiac surgery patients: a prospective observational study

    by Ling Xue, Shan He, Rajeev K. Singla, Qiong Qin, Yinglong Ding, Linsheng Liu, Xiaoliang Ding, Harbil Bediaga-Bañeres, Sonia Arrasate, Aliuska Durado-Sanchez, et al.

    Background: Warfarin is a common oral anticoagulant, and its effects vary widely among individuals. Numerous dose-prediction algorithms have been reported based on cross-sectional data generated via multiple linear regression or machine learning. This study aimed to construct an information fusion perturbation theory and machine-learning prediction model of warfarin blood levels based on clinical longitudinal data from cardiac surgery patients. Methods and material: The data of 246 patients were obtained from electronic medical records. Continuous variables were processed by calculating the distance of the raw data with the moving average (MA ∆vki(s j)), and categorical variables in different attribute groups were processed using Euclidean distance (ED ǁ∆vk(s j)ǁ). Regression and classification analyses were performed on the raw data, MA ∆vki(s j), and ED ǁ∆vk(s j)ǁ. Different machine-learning algorithms were chosen for the STATISTICA and WEKA software. Results: The random forest (RF) algorithm was the best for predicting continuous outputs using the raw data. The correlation coefficients of the RF algorithm were 0.978 and 0.595 for the training and validation sets, respectively, and the mean absolute errors were 0.135 and 0.362 for the training and validation sets, respectively. The proportion of ideal predictions of the RF algorithm was 59.0%. General discriminant analysis (GDA) was the best algorithm for predicting the categorical outputs using the MA ∆vki(s j) data. The GDA algorithm’s total true positive rate (TPR) was 95.4% and 95.6% for the training and validation sets, respectively, with MA ∆vki(s j) data. Conclusions: An information fusion perturbation theory and machine-learning model for predicting warfarin blood levels was established. A model based on the RF algorithm could be used to predict the target international normalized ratio (INR), and a model based on the GDA algorithm could be used to predict the probability of being within the target INR range under different clinical scenarios.


  • Open Access

    On the additive artificial intelligence-based discovery of nanoparticle neurodegenerative disease drug delivery systems

    by Shan He, Julen Segura Abarrategi, Harbil Bediaga, Sonia Arrasate, Humberto González-Díaz

    Neurodegenerative diseases are characterized by slowly progressing neuronal cell death. Conventional drug treatment strategies often fail because of poor solubility, low bioavailability, and the inability of the drugs to effectively cross the blood–brain barrier. Therefore, the development of new neurodegenerative disease drugs (NDDs) requires immediate attention. Nanoparticle (NP) systems are of increasing interest for transporting NDDs to the central nervous system. However, discovering effective nanoparticle neuronal disease drug delivery systems (N2D3Ss) is challenging because of the vast number of combinations of NP and NDD compounds, as well as the various assays involved. Artificial intelligence/machine learning (AI/ML) algorithms have the potential to accelerate this process by predicting the most promising NDD and NP candidates for assaying. Nevertheless, the relatively limited amount of reported data on N2D3S activity compared to assayed NDDs makes AI/ML analysis challenging. In this work, the IFPTML technique, which combines information fusion (IF), perturbation theory (PT), and machine learning (ML), was employed to address this challenge. Initially, we conducted the fusion into a unified dataset comprising 4403 NDD assays from ChEMBL and 260 NP cytotoxicity assays from journal articles. Through a resampling process, three new working datasets were generated, each containing 500,000 cases. We utilized linear discriminant analysis (LDA) along with artificial neural network (ANN) algorithms, such as multilayer perceptron (MLP) and deep learning networks (DLN), to construct linear and non-linear IFPTML models. The IFPTML-LDA models exhibited sensitivity (Sn) and specificity (Sp) values in the range of 70% to 73% (>375,000 training cases) and 70% to 80% (>125,000 validation cases), respectively. In contrast, the IFPTML-MLP and IFPTML-DLN achieved Sn and Sp values in the range of 85% to 86% for both training and validation series. Additionally, IFPTML-ANN models showed an area under the receiver operating curve (AUROC) of approximately 0.93 to 0.95. These results indicate that the IFPTML models could serve as valuable tools in the design of drug delivery systems for neurosciences.


  • Warfarin–A natural anticoagulant: A review of research trends for precision medication

    by Ling Xue, Rajeev K. Singla, Shan He, Sonia Arrasate, Humberto González-Díaz, Liyan Miao, Bairong Shen


  • Open Access

    On Additive Artificial Intelligence Discovery of Nanoparticle-Neurodegenerative Disease Drug Delivery Systems

    by Shan He, Julen Segura Abarrategi, Harbil Bediaga, Sonia Arrasate, Humberto González-Díaz

    Neurodegenerative diseases are characterized by slowly progressive neuronal death. Conventional treatment strategies often fail due to poor solubility, lower bioavailability, and the inability to effectively cross the Blood–Brain Barrier (BBB). Therefore, the development of new Neurodegenerative Disease Drugs (NDDs) requires immediate attention. Nanoparticle (NP) systems are increasingly of interest for transporting NDDs to the central nervous system. However, discovering effective Nanoparticle Neuronal Disease Drug Delivery Systems (N2D3S) is challenging due to the vast number of NP and NDDS compound combinations, as well as various assays involved. Artificial Intelligence/Machine Learning (AI/ML) algorithms have the potential to accelerate this process by predicting the most promising NDDS and NP candidates for assay. Nevertheless, the relatively limited amount of reported data on N2D3S activity compared to assayed NDDs makes AI/ML analysis challenging. In this work, the IFPTML technique, which combines Information Fusion (IF), Perturbation Theory (PT), and Machine Learning (ML), was employed to address this challenge. Initially, we conducted fusion into a unified dataset comprising 4403 NDDS assays from ChEMBL and 260 cytotoxicity NP assays from journal articles. Through a resampling process, three new working datasets were generated, each containing 500,000 cases. We utilized Linear Discriminant Analysis (LDA) along with Artificial Neural Networks (ANN) algorithms like Multi-Layer Perceptron (MLP) and Deep Learning Networks (DLN) to construct linear and non-linear IFPTML models, respectively. The IFPTML-LDA models exhibited Sensitivity (Sn) and Specificity (Sp) values in the range of 70% to 73% (>375K training cases) and 70% to 80% (>125K validation cases), respectively. Conversely, the IFPTML-MLP and IFPTML-DLN achieved Sn and Sp values in the range of 85% to 86% for both training and validation series. Additionally, IFPTML-ANN models showed an Area Under the Receiver Operating Curve (AUROC) of approximately 0.93 to 0.95. These results indicate that the IFPTML models could serve as valuable tools in the design of drug delivery systems for neurosciences.